[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-351452-105":59,"doc-detail-351452-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","upper-gastrointestinal-cancers-global-burden-profile-trends-contributors-and-attributable-change-in-life-expectancy-from-1990-to-2021","Upper gastrointestinal cancers global burden profile, trends, contributors, and attributable change in life expectancy from 1990 to 2021","","Upper gastrointestinal cancers, combining esophageal cancer and gastric cancer, remain a major global health burden with marked geographic unevenness in incidence and mortality. The study uses Global Burden of Disease 2021 data to quantify 1990–2021 incidence, mortality, and life-expectancy impacts across 21 regions, assessing trends via age-standardized rates and AAPC, and evaluating demographic and risk-attributable components. Decomposition estimates attribute life-expectancy changes to disease burden, supporting region-specific prevention priorities.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/upper-gastrointestinal-cancers-global-burden-profile-trends-contributors-and-attributable-change-in-life-expectancy-from-1990-to-2021/351452/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/upper-gastrointestinal-cancers-global-burden-profile-trends-contributors-and-attributable-change-in-life-expectancy-from-1990-to-2021/351452.png","ImageObject",300,407,{"name":92,"@type":93},"Taylor Morgan","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-27","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How does the study define upper gastrointestinal cancer, and why combine esophageal and gastric cancer?","Question",{"text":112,"@type":113},"It defines upper GI cancer as the combined burden of esophageal cancer and gastric cancer because they are anatomically contiguous, share common risk factors such as tobacco use, alcohol consumption, and dietary habits, and show similar geographic patterns in incidence.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What data and analytical methods are used to assess trends from 1990 to 2021?",{"text":117,"@type":113},"The study uses Global Burden of Disease (GBD) 2021 data and evaluates incidence, mortality, and life expectancy impacts across 21 world regions. Trends are quantified using age-standardized rates and AAPC, with demographic and risk-attributable contributions analyzed using a three-step decomposition method for life expectancy changes.",{"name":119,"@type":110,"acceptedAnswer":120},"What are the main findings about global burden and risk contributions?",{"text":121,"@type":113},"From 1990 to 2021, age-standardized incidence and mortality declined, but absolute incidence and deaths increased due to population growth and ageing. Tobacco remains the leading risk, accounting for 21.9% of deaths, and upper GI cancers contributed to a total of 0.24 years of life expectancy gained over the period.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},351452,1790143996,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":44,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},1099523885336,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Journal of the National Cancer Center 6 (2026) 166–174  \nContents lists available at ScienceDirect  \nJournal of the National Cancer Center  \njournal [homepage:](homepage: www.elsevier.com/locate/jncc)[ www.elsevier.com/locate/jncc](homepage: www.elsevier.com/locate/jncc)  \n| Full Length Article |  |  |  |\n| --- | --- | --- | --- |\n| Upper gastrointestinal cancers global burden proﬁle, trends, contributors, and attributable change in life expectancy from 1990 to 2021 |  |  | |\n| Yi Teng a,†, Haoyu Zhangb,†, Siyi He a, Mengdi Cao a, Qianru Li a, Nuopei Tan a, Jiachen Wang a, Yujie Wu a, Tianyi Li a, Yuanjie Zheng a, Changfa Xia a, Wanqing Chen a,∗\u003Cbr>a National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China\u003Cbr>b Sydney School of Public Health, The University of Sydney, Sydney, Australia |  |  |  |\n| a r t i c l e i n f o |  | a b s t r a c t |  |\n| Keywords:\u003Cbr>Upper gastrointestinal cancer Incidence\u003Cbr>Mortality\u003Cbr>Risk factors\u003Cbr>Ageing\u003Cbr>Life expectancy |  | Background: Upper gastrointestinal (GI) cancers, comprising esophageal cancer (EC) and gastric cancer (GC), remain a signiﬁcant global health burden with disproportionate geographic distribution of incidence and mortality. A comprehensive assessment of global and regional patterns and trends of upper GI cancer burden is essential to inform targeted prevention strategies.\u003Cbr>Methods: Data were sourced from the Global Burden of Disease (GBD) study 2021. We examined the incidence, mortality, and life expectancy (LE) impacts of upper GI cancers from 1990 to 2021 across 21 GBD world regions. Trends were assessed using age-standardized rates and average annual percentage change (AAPC). Nonmodiﬁable demographic factors and modiﬁable risk-attributable burdens were analyzed. A three-step decomposition method was applied to quantify the contribution of upper GI cancer to changes in LE.\u003Cbr>Results: In 2021, upper GI cancers accounted for 1.80 million new cases and 1.49 million deaths globally, with Asia contributing over 70% of the burden. Global age-standardized incidence and mortality rates for upper GI cancers declined from 1990 to 2021, with AAPC of-1.53% and-1.87%, respectively, although absolute incidence and deaths increased due to population growth and ageing, contributing to 1.13 million deaths for upper GI cancers. Population expansion and ageing drove increases in age-related deaths during the study period and were oﬀset by reduced incidence and case fatality. Risk-attributable deaths declined for most modiﬁable factors, with tobacco remaining the leading risk, responsible for 21.9% of all deaths. A total of 0.24 year of LE gained was attributable to upper GI cancers from 1990 to 2021. Regionally, high-income Asia Paciﬁc achieved the greatest gains in LE (0.67 years). GC predominantly contributed to the most gains, whereas EC mostly contributed to LE changes in Central and East Asia (0.27 years and 0.19 years, respectively).\u003Cbr>Conclusions: Although the burden of upper GI cancers has declined, progress is uneven, and the absolute burden remains high in Asia. Continued region-speciﬁc prevention, risk factor control, and equitable access to early detection and treatment are essential to further reduce the disease burden and close global disparities. |  |\n\n1. Introduction  \nUpper gastrointestinal (GI) cancers, speciﬁcally esophageal cancer (EC) and gastric cancer (GC), pose a signiﬁcant global health challenge due to their substantial morbidity and mortality. In this study, upper GI cancer is deﬁned as the combination of EC and GC, as they are anatomically contiguous, share many common risk factors including tobacco use,1 alcohol consumption,2 and dietary habits,3 , 4 and exhibit similar geographic distribution in incidence. Furthermore, GC screen-  \n∗ Corresponding author.  \nE-mail address: [chenwq@cicams.ac.cn](chenwq@cicams.ac.cn) (W. Chen).† These authors co","cbCaigDgpB20642E","https://ap.wps.com/l/cbCaigDgpB20642E","pdf",2345578,"English","# Introduction\n## Study rationale and definition of upper GI cancers\n## Geographic and gender disparities\n# Methods\n## Data source and study scope (1990–2021, 21 regions)\n## Trend metrics and decomposition approach\n## Risk-attributable and demographic-factor analysis\n# Results\n## Global burden in 2021 (incidence, mortality)\n## Trend changes and demographic effects (population growth, ageing)\n## Tobacco as leading risk and LE attribution\n## Regional differences in life-expectancy gains and contributors\n# Conclusions\n## Uneven progress and recommendations for prevention and equity","[{\"question\":\"How does the study define upper gastrointestinal cancer, and why combine esophageal and gastric cancer?\",\"answer\":\"It defines upper GI cancer as the combined burden of esophageal cancer and gastric cancer because they are anatomically contiguous, share common risk factors such as tobacco use, alcohol consumption, and dietary habits, and show similar geographic patterns in incidence.\"},{\"question\":\"What data and analytical methods are used to assess trends from 1990 to 2021?\",\"answer\":\"The study uses Global Burden of Disease (GBD) 2021 data and evaluates incidence, mortality, and life expectancy impacts across 21 world regions. Trends are quantified using age-standardized rates and AAPC, with demographic and risk-attributable contributions analyzed using a three-step decomposition method for life expectancy changes.\"},{\"question\":\"What are the main findings about global burden and risk contributions?\",\"answer\":\"From 1990 to 2021, age-standardized incidence and mortality declined, but absolute incidence and deaths increased due to population growth and ageing. Tobacco remains the leading risk, accounting for 21.9% of deaths, and upper GI cancers contributed to a total of 0.24 years of life expectancy gained over the period.\"}]","Upper gastrointestinal cancers global burden profile, trends, contributors, and attributable change in life expectancy from 1990 to 2021 | PDF",1790094250,23,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/637512a3d81558e7cc62797fa3a12629.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/25d7f30e20c8aa4b4e9483db83092413.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3b2800c7f5554f164946042c27ab7c5d.webp",981,735,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cf7effd895a4db866905a6e64a17b82a.webp",980,734]